Mr Michael Dale Lance Ii, CRNA | |
530 S Jackson St, Louisville, KY 40202-1675 | |
(502) 852-1735 | |
(502) 852-6056 |
Full Name | Mr Michael Dale Lance Ii |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 4 Years |
Location | 530 S Jackson St, Louisville, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063032001 | NPI | - | NPPES |
7100679990 | Medicaid | KY | |
300040935 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 3014694 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jewish Hospital & St Mary's Healthcare | Louisville, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Louisville Physicians Inc | 3476725599 | 1102 |
News Archive
Tuberculosis deserves an effort as "substantial" as the one mounted against swine flu "to develop a new vaccine," David McMurray, a TB expert at Texas A&M University System Health Science Center, writes in a Houston Chronicle opinion piece.
Among patients with Clostridium difficile infection (CDI) who recovered following standard treatment with the antibiotics metronidazole or vancomycin, oral administration of spores of a strain of C difficile that does not produce toxins colonized the gastrointestinal tract and significantly reduced CDI recurrence, according to a study in the May 5 issue of JAMA.
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
When President Donald Trump started touting hydroxychloroquine as "one of the biggest game changers" for treating COVID-19, researchers hoped electronic health records could quickly tell them if he was on the right track.
› Verified 9 days ago
Entity Name | University Of Louisville Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
Tuberculosis deserves an effort as "substantial" as the one mounted against swine flu "to develop a new vaccine," David McMurray, a TB expert at Texas A&M University System Health Science Center, writes in a Houston Chronicle opinion piece.
Among patients with Clostridium difficile infection (CDI) who recovered following standard treatment with the antibiotics metronidazole or vancomycin, oral administration of spores of a strain of C difficile that does not produce toxins colonized the gastrointestinal tract and significantly reduced CDI recurrence, according to a study in the May 5 issue of JAMA.
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
When President Donald Trump started touting hydroxychloroquine as "one of the biggest game changers" for treating COVID-19, researchers hoped electronic health records could quickly tell them if he was on the right track.
› Verified 9 days ago
Entity Name | Ema Anesthesia, Psc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104102268 PECOS PAC ID: 7911174552 Enrollment ID: O20191213001786 |
News Archive
Tuberculosis deserves an effort as "substantial" as the one mounted against swine flu "to develop a new vaccine," David McMurray, a TB expert at Texas A&M University System Health Science Center, writes in a Houston Chronicle opinion piece.
Among patients with Clostridium difficile infection (CDI) who recovered following standard treatment with the antibiotics metronidazole or vancomycin, oral administration of spores of a strain of C difficile that does not produce toxins colonized the gastrointestinal tract and significantly reduced CDI recurrence, according to a study in the May 5 issue of JAMA.
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
When President Donald Trump started touting hydroxychloroquine as "one of the biggest game changers" for treating COVID-19, researchers hoped electronic health records could quickly tell them if he was on the right track.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Michael Dale Lance Ii, CRNA Po Box 909, Louisville, KY 40201-0909 Ph: (502) 588-0328 | Mr Michael Dale Lance Ii, CRNA 530 S Jackson St, Louisville, KY 40202-1675 Ph: (502) 852-1735 |
News Archive
Tuberculosis deserves an effort as "substantial" as the one mounted against swine flu "to develop a new vaccine," David McMurray, a TB expert at Texas A&M University System Health Science Center, writes in a Houston Chronicle opinion piece.
Among patients with Clostridium difficile infection (CDI) who recovered following standard treatment with the antibiotics metronidazole or vancomycin, oral administration of spores of a strain of C difficile that does not produce toxins colonized the gastrointestinal tract and significantly reduced CDI recurrence, according to a study in the May 5 issue of JAMA.
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.
When President Donald Trump started touting hydroxychloroquine as "one of the biggest game changers" for treating COVID-19, researchers hoped electronic health records could quickly tell them if he was on the right track.
› Verified 9 days ago
Benjamin Martin Choi Sampedro, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 E Chestnut St, Louisville, KY 40202 Phone: 214-687-0001 | |
Mrs. Shelby Victoria Cofer, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 530 S Jackson St, Louisville, KY 40202 Phone: 502-562-3000 | |
Marian Antonette Cochiaosue-avery, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 530 S Jackson St, Louisville, KY 40202 Phone: 502-852-1735 Fax: 502-852-6056 | |
Jessica Earline Luvisi, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 231 E Chestnut St, Louisville, KY 40202 Phone: 502-629-6000 | |
Chad Riddle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4034 Saint Ives Ct, Louisville, KY 40207 Phone: 502-640-8349 Fax: 502-749-9202 | |
Mr. Scott M. Beyl, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 530 S Jackson St, Louisville, KY 40202 Phone: 502-852-6901 Fax: 502-852-6056 | |
Lauren Elise Coles, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 530 S Jackson St, Louisville, KY 40202 Phone: 502-852-1735 Fax: 502-852-6056 |